Search Saint Luke's

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Saint Luke’s receives $10 million endowment to establish first institute dedicated to studying unique aspects of heart conditions in women.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

The new Saint Luke’s Muriel I. Kauffman Institute for Women’s Cardiovascular Research is the first of its kind dedicated to studying unique aspects of heart conditions in women.

Percutaneous coronary intervention is associated with significant short-term improvements in high-risk patients with complex coronary artery disease who are ineligible for coronary artery bypass grafting, according to a new analysis.

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.

In 2021, Saint Luke’s launched its heart team-led Wound Transition Program, which went on to surpass national goals and cut PAD amputation rates in half.

Get With The Guidelines put the expertise of the American Heart Association and American Stroke Association to work for hospitals nationwide, helping ensure patient care is aligned with the latest evidence- and research-based guidelines.

The use of prescription drugs for ADHD has significantly increased in the past few decades. James O'Keefe, MD studies the link between these medications and cardiovascular events.